Azacitidine in adult patients with acute myeloid leukemia.

Andre C Schuh; Hartmut Döhner; Lisa Pleyer; John F Seymour; Pierre Fenaux; Hervé Dombret

doi:10.1016/j.critrevonc.2017.05.010

Azacitidine in adult patients with acute myeloid leukemia.

Andre C Schuh, Hartmut Döhner, Lisa Pleyer (Co-author), John F Seymour, Pierre Fenaux, Hervé Dombret

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Review article › peer-review

43 Citations (Web of Science)

Original language	English
Pages (from-to)	159-177
Journal	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume	116
DOIs	https://doi.org/10.1016/j.critrevonc.2017.05.010
Publication status	Published - 2017

Keywords

RISK MYELODYSPLASTIC SYNDROMES
CONVENTIONAL CARE REGIMENS
LOW-DOSE CYTARABINE
NEWLY-DIAGNOSED AML
QUALITY-OF-LIFE
PHASE-III TRIAL
WORLD-HEALTH-ORGANIZATION
TRANS-RETINOIC ACID
OLDER PATIENTS
INTENSIVE CHEMOTHERAPY

Access to Document

10.1016/j.critrevonc.2017.05.010

Cite this

Schuh, A. C., Döhner, H., Pleyer, L., Seymour, J. F., Fenaux, P., & Dombret, H. (2017). Azacitidine in adult patients with acute myeloid leukemia. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , 116, 159-177. https://doi.org/10.1016/j.critrevonc.2017.05.010

Schuh, Andre C ; Döhner, Hartmut ; Pleyer, Lisa et al. / Azacitidine in adult patients with acute myeloid leukemia. In: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2017 ; Vol. 116. pp. 159-177.

@article{6e194a488c5e40df86966a315760c522,

title = "Azacitidine in adult patients with acute myeloid leukemia.",

keywords = "RISK MYELODYSPLASTIC SYNDROMES, CONVENTIONAL CARE REGIMENS, LOW-DOSE CYTARABINE, NEWLY-DIAGNOSED AML, QUALITY-OF-LIFE, PHASE-III TRIAL, WORLD-HEALTH-ORGANIZATION, TRANS-RETINOIC ACID, OLDER PATIENTS, INTENSIVE CHEMOTHERAPY",

author = "Schuh, \{Andre C\} and Hartmut D{\"o}hner and Lisa Pleyer and Seymour, \{John F\} and Pierre Fenaux and Herv{\'e} Dombret",

note = "Pleyer: 3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Salzburg, Austria",

year = "2017",

doi = "10.1016/j.critrevonc.2017.05.010",

language = "English",

volume = "116",

pages = "159--177",

journal = "CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY ",

issn = "1040-8428",

}

Schuh, AC, Döhner, H, Pleyer, L, Seymour, JF, Fenaux, P & Dombret, H 2017, 'Azacitidine in adult patients with acute myeloid leukemia.', CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol. 116, pp. 159-177. https://doi.org/10.1016/j.critrevonc.2017.05.010

Azacitidine in adult patients with acute myeloid leukemia. / Schuh, Andre C; Döhner, Hartmut; Pleyer, Lisa (Co-author) et al.
In: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , Vol. 116, 2017, p. 159-177.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - Azacitidine in adult patients with acute myeloid leukemia.

AU - Schuh, Andre C

AU - Döhner, Hartmut

AU - Pleyer, Lisa

AU - Seymour, John F

AU - Fenaux, Pierre

AU - Dombret, Hervé

N1 - Pleyer: 3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Salzburg, Austria

PY - 2017

Y1 - 2017

KW - RISK MYELODYSPLASTIC SYNDROMES

KW - CONVENTIONAL CARE REGIMENS

KW - LOW-DOSE CYTARABINE

KW - NEWLY-DIAGNOSED AML

KW - QUALITY-OF-LIFE

KW - PHASE-III TRIAL

KW - WORLD-HEALTH-ORGANIZATION

KW - TRANS-RETINOIC ACID

KW - OLDER PATIENTS

KW - INTENSIVE CHEMOTHERAPY

U2 - 10.1016/j.critrevonc.2017.05.010

DO - 10.1016/j.critrevonc.2017.05.010

M3 - Review article

C2 - 28693797

SN - 1040-8428

VL - 116

SP - 159

EP - 177

JO - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

JF - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

ER -

Schuh AC, Döhner H, Pleyer L, Seymour JF, Fenaux P, Dombret H. Azacitidine in adult patients with acute myeloid leukemia. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY . 2017;116:159-177. doi: 10.1016/j.critrevonc.2017.05.010